ClinicalTrials.gg
RecruitingNCT06605820SHAREUpdated Jun 4, 2025

Shared Decision-making and Antimicrobial Stewardship in Secondary Care

An observational study in Antibiotic Prescribing is the Study Focus (no Condition), sponsored by Royal Cornwall Hospitals Trust. Recruiting at 2 sites in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-04.

Sponsored by Royal Cornwall Hospitals Trust · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Sep 2024; still recruiting 2 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

To identify opportunities for antibiotic prescribing shared decision making between patients and prescribers in secondary care.

Read the detailed description

This is a qualitative study with patients and clinicians in secondary care.

We will use semi-structured interviews with patients and clinicians to address the research question. Patients that have received antibiotics during a recent inpatient stay will be identified using the hospital electronic prescribing system and a letter inviting study participation will be included in their discharge medication pack. Senior prescribing decision makers will be recruited from participating hospitals. In total, we hope to carry out up to 50 interviews with patients and clinicians.

02

Conditions studied

  • Antibiotic Prescribing is the Study Focus (no Condition)
03

In context

Lead sponsor

Royal Cornwall Hospitals Trust is the lead sponsor of 24 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

We will use semi-structured interviews with patients and clinicians to address the research question. Patients that have received antibiotics during a recent inpatient stay will be identified using the hospital electronic prescribing system and a letter inviting study participation will be included in their discharge medication pack. Senior prescribing decision makers will be recruited from participating hospitals.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For clinicians:

  • Participant is willing and able to give for participation in the study.
  • Senior registrar or consultant medical or surgical doctor working at participating hospitals and caring for inpatients.
  • Fluent in English.

For patients:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 16 years or above (no upper age limit).
  • Good standard of speaking English and able to read and understand study materials.
  • Received antibiotic for treatment of suspected or confirmed bacterial infection during inpatient stay.

Exclusion criteria

Exclusion Criteria:

  • For clinicians:

    • Prescribers not currently caring for inpatients

For patients:

  • Patient who received prophylaxis antibiotics only
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Other
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients

    Other: None - Interview Only

  • Healthcare workers

    Other: None - Interview Only

Interventions

  • OtherNone - Interview Only

    None - Interview Only

06

What researchers measure

Primary outcomes

  1. Patient and prescriber views and experiences with shared decision making (SDM) around antibiotic prescribing in secondary care and to identify further opportunities for SDM.

    Data will be analysed using thematic analysis

    Time frame: 1 year

07

Study locations

2 of 2 sites recruiting
  • Royal Cornwall Hospital
    Truro, Cornwall TR1 3LJ, United Kingdom
    Recruiting
    • Verity Teague · Contactrcht.sponsor@nhs.net · 01872256429
    • Neil Powell, Pharmacist · Principal investigator
  • Chelsea and Westminster Hospital
    Truro, TR1 3LJ, United Kingdom
    Recruiting
    • Verity Teague · Contactrcht.sponsor@nhs.net · 01872256429
    • Stephen Hughes, Pharmacist · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Jul 2025, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2024
First posted
Sep 20, 2024
StartActual
Sep 3, 2024
Primary completionEst.
Jul 2025
CompletionEst.
Jul 2025
Last update
Jun 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06605820
Lead sponsor
Royal Cornwall Hospitals Trust
Responsible party
Sponsor
First posted
Sep 20, 2024
Start date
Sep 3, 2024
Primary completion
Jul 2025 (estimated)
Completion
Jul 2025 (estimated)
Last update
Jun 4, 2025

Study contacts

Verity Teague
Contact
rcht.sponsor@nhs.net
44 01872256429

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion